These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3860272)

  • 21. Gilles de la Tourette disease in multiply disabled children.
    Kerbeshian J; Burd L; Fisher W; Martsolf JT; Wikenhaiser M
    Rehabil Lit; 1985; 46(9-10):255-8. PubMed ID: 3865270
    [No Abstract]   [Full Text] [Related]  

  • 22. [Disorders associated with the Gilles de la Tourette syndrome].
    Muñoz-Yunta JA; Freixas A; Valls-Santasusana A; Gómez C
    Rev Neurol; 1999 Feb; 28 Suppl 2():S156-9. PubMed ID: 10778506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gilles de la Tourette: The history of the man and his illness; a medical historical study].
    Gilson F
    Tijdschr Psychiatr; 2012; 54(7):427-36. PubMed ID: 22811054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Social and emotional adjustment in children affected with Gilles de la Tourette's syndrome: associations with ADHD and family functioning. Attention Deficit Hyperactivity Disorder.
    Carter AS; O'Donnell DA; Schultz RT; Scahill L; Leckman JF; Pauls DL
    J Child Psychol Psychiatry; 2000 Feb; 41(2):215-23. PubMed ID: 10750547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vomiting and retching in Gilles de la Tourette syndrome: a report of ten cases and a review of the literature.
    Rickards H; Robertson MM
    Mov Disord; 1997 Jul; 12(4):531-5. PubMed ID: 9251071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Movement lateralization and bimanual coordination in children with Tourette syndrome.
    Avanzino L; Martino D; Bove M; De Grandis E; Tacchino A; Pelosin E; Mirabelli M; Veneselli E; Abbruzzese G
    Mov Disord; 2011 Sep; 26(11):2114-8. PubMed ID: 21932301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of methylphenidate and imipramine in Gilles de la Tourette's disease in children.
    Fras I; Karlavage J
    Am J Psychiatry; 1977 Feb; 134(2):195-7. PubMed ID: 264771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical analysis of Gilles de la Tourette syndrome based on 126 cases.
    Janik P; Kalbarczyk A; Sitek M
    Neurol Neurochir Pol; 2007; 41(5):381-7. PubMed ID: 18033637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Gilles de la Tourette syndrome: a principal component factor analytic study of a large pedigree.
    Robertson MM; Cavanna AE
    Psychiatr Genet; 2007 Jun; 17(3):143-52. PubMed ID: 17417057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three Cases of Palatal Tics and Gilles De La Tourette Syndrome.
    Rizzo R; Cath D; Pavone P; Tijssen M; Robertson MM
    J Child Neurol; 2015 Aug; 30(9):1199-203. PubMed ID: 25246300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients.
    Jakubovski E; Müller-Vahl K
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28796166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pathophysiology of echopraxia/echolalia: relevance to Gilles de la Tourette syndrome.
    Ganos C; Ogrzal T; Schnitzler A; Münchau A
    Mov Disord; 2012 Sep; 27(10):1222-9. PubMed ID: 22807284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deleterious effects of drugs used for hyperactivity on patients with Gilles de la Tourette syndrome.
    Sleator EK
    Clin Pediatr (Phila); 1980 Jul; 19(7):453-4. PubMed ID: 6929749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quetiapine in the treatment of the Gilles de la Tourette syndrome. A case study].
    Neves Ramos D; van West D; van Strien AP
    Tijdschr Psychiatr; 2007; 49(4):263-7. PubMed ID: 17436213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gilles de la Tourette syndrome in India: two cases.
    Eapen V; Srinath S
    Psychol Rep; 1992 Apr; 70(2):667-8. PubMed ID: 1598386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered structural connectivity of cortico-striato-pallido-thalamic networks in Gilles de la Tourette syndrome.
    Worbe Y; Marrakchi-Kacem L; Lecomte S; Valabregue R; Poupon F; Guevara P; Tucholka A; Mangin JF; Vidailhet M; Lehericy S; Hartmann A; Poupon C
    Brain; 2015 Feb; 138(Pt 2):472-82. PubMed ID: 25392196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tourette disorder and bipolar symptomatology in childhood and adolescence.
    Kerbeshian J; Burd L
    Can J Psychiatry; 1989 Apr; 34(3):230-3. PubMed ID: 2497949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gilles de la Tourette syndrome: a 20-month study of the effects of stressful life events and haloperidol on symptom frequency.
    Surwillo WW; Shafii M; Barrett CL
    J Nerv Ment Dis; 1978 Nov; 166(11):812-6. PubMed ID: 281456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Compulsive disorder and Gilles de la Tourette syndrome. On the differential diagnosis of organic and psychogenic compulsive symptoms].
    Müller N; Putz A; Straube A; Kathmann N
    Nervenarzt; 1995 May; 66(5):372-8. PubMed ID: 7609819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gilles de la Tourette's disease: present state of diagnosis and therapy].
    Asam U
    Acta Paedopsychiatr; 1978 Sep; 43(5-6):267-76. PubMed ID: 360775
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.